Patents Assigned to EMPLICURE AB
  • Devices for evaporation and inhalation of active agents
    Patent number: 11202871
    Abstract: There is provided an inhalation device for delivering a deliverable agent in the form of an aerosol or vapour to a user. The device comprises a solid, porous carrier material having a defined porosity, and a deliverable agent located within the pores of the carrier material. The device is operable to heat the carrier material and vaporise the deliverable agent. Deliverable agents that may be delivered to the user include active pharmaceutical ingredients. Suitable materials for the porous carrier material include chemically bonded ceramic materials and geopolymeric materials.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: December 21, 2021
    Assignee: EMPLICURE AB
    Inventor: Håkan Engqvist
  • Transdermal drug administration device
    Patent number: 10736838
    Abstract: A transdermal drug administration device comprising a drug delivery element (10) defining a contact surface (12) for location, in use, against a patient's skin. The drug delivery element (10) includes a sustained-release pharmaceutical composition. The composition comprises a network of a carrier material having a high mechanical strength and an active pharmaceutical ingredient. The active pharmaceutical ingredient is co-formedly interspersed within pores in the solid, continuous network of the carrier material.
    Type: Grant
    Filed: April 5, 2019
    Date of Patent: August 11, 2020
    Assignee: Emplicure AB
    Inventors: Håkan Engqvist, Susanne Bredenberg, Anders Petterson, Thomas Lundqvist, Anna Dahlgren, Anders Sågström
  • Abuse resistant formula
    Patent number: 10543203
    Abstract: There is provided a sustained-release pharmaceutical composition comprising a solid, continuous network comprising an excipient with a high mechanical strength, which network also comprises pores, within which pores is interspersed a mixture of an active ingredient and a film-forming agent, characterised in that said pores are formed during the production of the composition. Compositions of the invention find particularly utility as abuse-resistant formulations comprising opioid analgesics that may be employed in the treatment of chronic pain.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: January 28, 2020
    Assignee: Emplicure AB
    Inventors: Susanne Bredenberg, Anna Dahlgren, Anders Sågström, Håkan Engqvist
  • Transdermal drug administration device
    Patent number: 10251834
    Abstract: A transdermal drug administration device comprising a drug delivery element (10) defining a contact surface (12) for location, in use, against a patient's skin. The drug delivery element (10) includes a sustained-release pharmaceutical composition. The composition comprises a network of a carrier material having a high mechanical strength and an active pharmaceutical ingredient. The active pharmaceutical ingredient is co-formedly interspersed within pores in the solid, continuous network of the carrier material.
    Type: Grant
    Filed: September 5, 2011
    Date of Patent: April 9, 2019
    Assignee: EMPLICURE AB
    Inventors: Håkan Engqvist, Susanne Bredenberg, Anders Pettersson, Thomas Lundqvist, Anna Dahlgren, Anders Sågström
  • Composition for sustained drug delivery comprising geopolymeric binder
    Patent number: 10092652
    Abstract: The present invention relates to a sustained release medical composition comprising an active pharmaceutical ingredient and a geopolymeric binder. Preferably the active pharmaceutical ingredient is combined with the geopolymeric binder during the formation of that binder.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: October 9, 2018
    Assignee: Emplicure AB
    Inventor: Hakan Engqvist
  • Abuse resistant formula
    Patent number: 9622972
    Abstract: There is provided a sustained-release pharmaceutical composition comprising a solid, continuous network comprising an excipient with a high mechanical strength, which network also comprises pores, within which pores is interspersed a mixture of an active ingredient and a film-forming agent, characterized in that said pores are formed during the production of the composition. Compositions of the invention find particularly utility as abuse-resistant formulations comprising opioid analgesics that may be employed in the treatment of chronic pain.
    Type: Grant
    Filed: March 2, 2010
    Date of Patent: April 18, 2017
    Assignee: Emplicure AB
    Inventors: Susanne Bredenberg, Anna Dahlgren, Anders Sågström, Håkan Engqvist
  • Composition for sustained drug delivery comprising geopolymeric binder
    Patent number: 9486527
    Abstract: The present invention relates to a sustained release medical composition comprising an active pharmaceutical ingredient and a geopolymeric binder. Preferably the active pharmaceutical ingredient is combined with the geopolymeric binder during the formation of that binder.
    Type: Grant
    Filed: May 7, 2010
    Date of Patent: November 8, 2016
    Assignee: EMPLICURE AB
    Inventor: Hakan Engqvist